Clinical trial
Biomarkers to Enhance Early Schizophrenia Treatment
NCT06969755
Study timeline
Study start (actual)2024-09-04Date precision: day
Registry last updated2026-07-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophenia Disorderunresolved
Interventions
aripiprazoleDRUG · verified · RxNorm: aripiprazole
risperidoneDRUG · verified · RxNorm: risperidone
clozapineDRUG · verified · RxNorm: clozapine
Sponsors & collaborators
Northwell Healthlead sponsor
National Institute of Mental Health (NIMH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06969755 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.